Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 14, 2022
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
[ Wed, Dec 14th 2022
] - WOPRAI
Alex Thompson Initiated (TVTX) at Hold and Held Target at $22 on, Dec 14th, 2022
Alex Thompson of Stifel, Initiated "Travere Therapeutics, Inc." (TVTX) at Hold and Held Target at $22 on, Dec 14th, 2022.
Alex has made no other calls on TVTX in the last 4 months.
There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Alex's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Alex
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $38 on, Thursday, October 20th, 2022
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $36 on, Monday, October 17th, 2022
- Do Kim of "Piper Sandler" Maintained at Buy with Decreased Target to $38 on, Friday, October 14th, 2022
